Industry News
Palbociclib shows promise in patients with hormone-resistant breast cancer
2/25/2015
Targeted therapy drug recently approved by FDA for use in newly metastatic breast cancer patientsPalbociclib, an investigational oral medication that works by blocking molecules responsible for...
Customized DNA rings aid early cancer detection in mice, Stanford study finds
2/25/2015
Imagine: You pop a pill into your mouth and swallow it. It dissolves, releasing tiny particles that are absorbed and cause only cancerous cells to secrete a specific protein into your bloodstream.
Small molecule might help reduce cancer in at-risk population, Stanford study finds
2/25/2015
Researchers at the Stanford University School of Medicine have found that by changing the selectivity of an enzyme, a small molecule could potentially be used to decrease the likelihood of...
Certain factors influence whether cancer patients involve family members in treatment decisions
2/25/2015
Family members often play an important role in providing care for patients with cancer, but which patients are more or less likely to involve family members in decisions regarding their care is not...
Palbociclib shows promise in patients with hormone-resistant breast cancer
2/25/2015
Targeted therapy drug recently approved by FDA for use in newly metastatic breast cancer patientsPalbociclib, an investigational oral medication that works by blocking molecules responsible for...
Lack of awareness of ovarian cancer symptoms, especially among women at greatest risk
2/24/2015
Cancer Australia survey findings released for Teal Ribbon Day, show that 45 per cent of women surveyed were unable to identify any symptom of ovarian cancer, with women at greatest risk, aged 60...
Discovery of the genetic fingerprint of aggressive colon tumours
2/24/2015
About 40-50% of all colorectal patients relapse in the form of metastasis. In the last three years, several molecular classifications have been proposed to identify colorectal cancer patients at...
Lack of awareness of ovarian cancer symptoms, especially among women at greatest risk
2/24/2015
Cancer Australia survey findings released for Teal Ribbon Day, show that 45 per cent of women surveyed were unable to identify any symptom of ovarian cancer, with women at greatest risk, aged 60...
Discovery of the genetic fingerprint of aggressive colon tumours
2/24/2015
About 40-50% of all colorectal patients relapse in the form of metastasis. In the last three years, several molecular classifications have been proposed to identify colorectal cancer patients at...
New HPV approved after international phase 2/3 trial involving Moffitt Cancer Center
2/24/2015
Vaccine protects boys and girls against nine HPV types known to cause cancer and other diseasesApproximately 12,000 women are diagnosed with cervical cancer each year in the United States and...